Pharmaceutical

FDA cracks down on online retailers selling unapproved GLP-1 agonists

The FDA has issued warning letters to two online sellers for selling unapproved versions of semaglutide and tirzepatide.

Feb 14, 2024 - 18:00
FDA cracks down on online retailers selling unapproved GLP-1 agonists
The FDA has issued warning letters to two online sellers for selling unapproved versions of semaglutide and tirzepatide.
Read the original article

Tags:

Previous Article

SCOPE: Changing protocol language and site actions are key to making trials incl...

Next Article

BMS signs $674m GenAI drug discovery deal with VantAI

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Apple pauses sales of latest watches in the U.S. after ITC decision

STAT+: Apple pauses sales of latest watches in the U.S....

Dec 19, 2023

To build trust among LA’s unhoused, a street medicine team turns to technology

To build trust among LA’s unhoused, a street medicine t...

Apr 5, 2023

SK bioscience to expand vaccine manufacturing plant in South Korea

SK bioscience to expand vaccine manufacturing plant in ...

Mar 9, 2024